The role of blood biomarkers in predicting the outcome of ischemic stroke
- Authors: Gulieva M.S.1, Bagmanian S.D.1, Chukanova A.S.1, Chukanova E.I.1
-
Affiliations:
- Pirogov Russian National Research Medical University
- Issue: Vol 22, No 9 (2020)
- Pages: 28-32
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/95339
- DOI: https://doi.org/10.26442/20751753.2020.9.200284
- ID: 95339
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Maiia S. Gulieva
Pirogov Russian National Research Medical University
Email: m.gulieva2014@yandex.ru
ст. лаборант, каф. неврологии, нейрохирургии и медицинской генетики лечебного фак-та Moscow, Russia
Sona D. Bagmanian
Pirogov Russian National Research Medical Universityст. лаборант, каф. неврологии, нейрохирургии и медицинской генетики лечебного фак-та Moscow, Russia
Anna S. Chukanova
Pirogov Russian National Research Medical Universityканд. мед. наук, доц. каф. неврологии, нейрохирургии и медицинской генетики лечебного фак-та Moscow, Russia
Elena I. Chukanova
Pirogov Russian National Research Medical Universityд-р мед. наук, проф. каф. неврологии, нейрохирургии и медицинской генетики лечебного фак-та Moscow, Russia
References
- Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res 2017; 120 (3): 439-48. doi: 10.1161/CIRCRESAHA.116.308413
- Рябухин И.А. Нейроспецифические белки в оценке проницаемости гематоэнцефалического барьера человека и животных. Дис.. д-ра мед. наук. М., 2004.
- Блинов Д.В. Современные представления о роли нарушения резистентности гематоэнцефалического барьера в патогенезе заболеваний ЦНС. Часть 2: функции и механизмы повреждения гематоэнцефалического барьера. Эпилепсия и пароксизмальные состояния. 2014; 6 (1): 70-84.
- Fischer S, Clauss M, Wiesnet M et al. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 1999; 276: 812-20.
- Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994; 25: 558-65.
- Barone FC, Clerk RK, Price W. Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res 1993; 1: 71-82.
- Herrmann M, Jost S, Kutz S et al. Temporal profile of release of neurobiochemical markers of brain damage after traumatic brain injury is associated with intracranial pathology as demonstrated in cranial computerized tomography. J Neurotrauma 2000; 17: 113-22.
- Herrmann M, Elirenreich H. Brain derived proteins as markers of acute stroke: their relation to pathophysiology, outcome prediction and neuroprotective drug monitoring. Restor Neurol Neurosci 2003;21: 177-90.
- Chekhonin VP, Zhirkov YA, Belyaeva IA et al. Serum time course of two brain-specific proteins, alpha(l) brain globulin and neuron-specific enolase, in tick-born encephalitis and Lyme disease. Clin Chim Acta 2002; 320: 117-25.
- Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Ne-urochem Res 2000; 25: 1439-51.
- Engvall E, Perlman P Enzyme-linked immunoadsorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochem 1971; 8: 871-9.
- Чехонин В.П., Жирков Ю.А., Турина О.И. и др. Количественно-кинетические параметры элиминации нейроспецифических антигенов и антител к ним при некоторых нервно-психических заболеваниях. Рос.психиатрич. журн.2000;3:4-8.
- Perry LA, Lucarelli T, Penny-Dimri JC et al. Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: Systematic review and meta-analysis of diagnostic test accuracy. Int J Stroke 2019; 14 (4): 390-9. doi: 10.1177/1747493018806167
- Nylen K, Csajbok LZ, Ost M et al. Serum glial fibrillary acidic protein is related to focal brain injury and outcome after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38 (5): 1489-94.
- Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965; 19: 739-44.
- Donato R. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637-68.
- Saengen AK, Christenson RN. Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation and Treatment. Clin Chem 2010; 56 (1): 21-33.
- Harish Kumar, Manoj Lakhotia, Hansraj Pahadiya, Jagdish Singh. To study the correlation of serum S-100 protein level with the severity of stroke and its prognostic implication. J Neurosci Rural Pract 2015; 6 (3): 326-30. doi: 10.4103/0976-3147.158751
- Foerch C, Singer OC, Neumann-Haefelin T et al. Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction. Arch Neurol 2005; 62 (7): 1130-4.
- Dassan P, Keir G, Brown MM. Criteria for a clinically informative serum biomarker in acute ischaemic stroke: a review of S100B. Cerebrovasc Dis 2009; 27 (3): 295-302. doi: 10.1159/000199468
- Hatfield R, McKernan R. CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res 1992; 577: 249-52.
- Woertgen C, Rothoerl RD, Brawanski A. Neuron-specific enolase serum levels after controlled cortical impact injury in the rat. J Neurotrauma 2001; 18: 569-73.
- Haupt WF, Chopan G, Sobesky J et al. Prognostic value of somatosensory evoked potentials, neuron-specific enolase, and S100 for short-term outcome in ischemic stroke. J Neurophysiol 2016; 115: 1273-8.
- Stevens H, Jakobs C, de Jager AE et al. Neurone-specific enolase and N-acetyl-aspartate as potential peripheral markers of ischaemic stroke. Eur J Clin Invest 1999; 29: 6-11.
- Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994; 25: 558-65.
- Bharosay A, Bharosay VV, Varma M et al. Correlation of brain biomarker Neuron specific enolase (NSE) with degree of disability and neurological worsening in cerebrovascular stroke. Indian J Clin Biochem 2012; 27 (2): 186-90.
- Wunderlich MT, Ebert AD, Kratz T et al. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999; 30: 1190-5.
- Hill MD, Jackowski G, Bayer N et al. Biochemical markers in acute ischemic stroke. CMAJ 2000; 162:1139-40.
- Fassbender K, Schmidt R, Schreiner A et al. Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke. J Neurol Sci 1997; 148 (1): 101-5.
- Cunningham RT, Watt M, Winder J et al. Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest 1996; 26 (4): 298-303.
- Cunningham RT, Young IS, Winder J et al. Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest 1991; 21 (5): 497-500.
- Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997; 28 (10): 1956-60.
- Hasan N, McColgan P, Bentley P et al. Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol 2012; 74: 230-40.
- Martinez-Sanchez P, Gutierrez-Fernandez M, Fuentes B et al. Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models. J Transl Med 2014; 12: 220.
- Mehta SL, Manhas N, Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res Rev 2007; 4: 34-66. https://doi.org/10.1016Zj.brainresrev.2006.11.003
- Niu FN, Zhang X, Hu XM et al. Targeted mutation of Fas ligand gene attenuates brain inflammation in experimental stroke. Brain Behavior Immunity 2012; 26 (1): 61-71. doi: 10.1016/j.bbi.2011.07.235
- Mahovic D, Zurak N, Lakusic N et al. The dynamics of soluble Fas/APO 1 apoptotic biochemical marker in acute ischemic stroke patients. Adv Med Sci 2013; 58 (2): 298-303. doi: 10.2478/ams-2013-0014
- Сергеева С.П., Савин А.А., Архипов В.В. и др. Прогнозирование исхода острого периода ишемического инсульта: роль маркеров апоптоза. Клиническая неврология. 2017; 11 (1): 21-7.
- Чумаков П.М. Белок р53 и его универсальные функции в многоклеточном организме. Успехи биологической химии. 2007; 47: 3-52.
- Stanne TM, Aberg ND, Nilsson S et al. Low circulating acute brain-derived neurotrophic factor levels are associated with poor long-term functional outcome after ischemic stroke. Stroke 2016; 47 (7): 1943-5.
- Filichia E, Shen H, Zhou X et al. Forebrain neuronal specific ablation of p53 gene provides protection in a cortical ischemic stroke model. J Neuroscience 2015; 295: 1-10.
- Кольцова К.В. Роль полиморфных вариантов генов, участвующих в рецепторном пути индукции апоптоза (FADD, Fas и каспазы-8) в патогенезе ишемического инсульта. Дис.. канд. мед. наук. М., 2007.
- Чернышева Е.Н., Панова Т.Н. Индуктор апоптоза - белок р53 и инсулинорезистентность при метаболическом синдроме. Кубанский науч. мед. вестн. 2012; 131 (2): 186-90.
- Matsuo R, Ago T Kamouchi M et al. Clinical significance of plasma VEGF value in ischemic stroke -Research for biomarkers in ischemic stroke (rebios) study. BMC Neurol 2013; 13: 32.
- Lee SC, Lee KY, Kim YJ et al. Serum VEGF levels in acute ischaemic strokes are correlated with long-term prognosis. Eur J Neurol 2010; 17: 45-51.
- Putaala J, Metso AJ, Metso TM et al. Analysis of 1008 Consecutive Patients Aged 15 to 49 With First-Ever Ischemic Stroke: The Helsinki Young Stroke Registry. Stroke 2009; 40: 1195-203.
- Kumar S, Parkash J, Kataria H, Kaur G. Interactive effect of excitotoxic injury and dietary restriction on neurogenesis and neurotrophic factors in adult male rat brain. Neurosci Res 2009; 65 (4): 367-74.
- Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 2005; 76 (2): 99-125.
- Walz C, Jungling K, Lessmann V, Gottmann K. Presynaptic plasticity in an immature neocortical network requires NMDA receptor activation and BDNF release. J Neurophysiol 2006; 96: 3512-6.
- Kramar EA, Chen LY, Lauterborn JC et al. BDNF upregulation rescues synaptic plasticity in middleaged ovariectomized rats. Neurobiol Aging 2010; 33: 708-19.
- Yamashita K, Wiessner C, Lindholm D et al. Post-41 occlusion treatment with BDNF reduces infarct size in a model of permanent occlusion of 42 the middle cerebral artery in rat. Metab Brain Dis 1997; 12: 271-80.
- Schabitz WR, Berger C, Kollmar R et al. Effect of brain-derived neurotrophic factor treatment and forced arm 24 use on functional motor recovery after small cortical ischemia. Stroke 2004; 35: 992-7.
- Jiang Y, Wei N, Zhu J et al. Effects of brainderived neurotrophic factor on local inflammation in experimental stroke of rat. Mediat Inflamm 2010; 2010: 1-10.
- Bus BA, Molendijk ML, Penninx BJ et al. Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology 2011; 36: 228-39.
- McAllister AK, Lo DC, Katz LC. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 1995; 15: 791-803.
- Lee J, Seroogy KB, Mattson MP. Dietary restriction enhances neurotrophins expression and neurogenesis in the hippocampus of adult mice. J Neurochem 2002; 80 (3): 539-47.
- Lu B, Pang PT, Woo NH. The yin and yang of neurotrophin action. Nat Rev Neurosci 2005; 6 (8): 603-14.
- Yang L, Zhang Z, Sun D et al. Low serum BDNF may indicate the development of PSD in patients with acute ischemic stroke. Int J Geriatr Psychiatry 2011; 26 (5): 495-502.
- Еремова Н.М. Роль «отдаленных последствий ишемии» (нейротрофической дисфункции, аутоиммунной и воспалительной реакций) в патогенезе ишемического инсульта. Дис. канд. мед. наук. М., 2003.
- Pikula A, Beiser AS, Chen TC et al. Serum brain-derived neurotrophic factor and vascular endothelial growth factor levels are associated with risk of stroke and vascular brain injury: Framingham Study. Stroke 2013; 44: 2768-75.
- Hope TM, Seghier ML, Leff AP, Price CJ. Predicting outcome and recovery after stroke with lesions extracted from MRI images. Neuroimage Clin 2013; 2: 424-33.
- Luan X, Qiu H, Hong X et al. High serum nerve growth factor concentrations are associated with good functional outcome at 3 months following acute ischemic stroke. Clin Chim Acta 2019; 488: 20-4. doi: 10.1016/j.cca.2018.10.030
- Lai YJ, Hanneman SK, Casarez RL et al. Blood biomarkers for physical recovery in ischemic stroke: a systematic review. Am J Transl Res 2019; 11 (8): 4603-13.